In the case of a possible tumor suppressor, BNIP3L, the combination of TFs FOS and PU1 binding to the gene’s promoter (as observed in GM12878 cells) predicted the gene’s expression accurately only in B-cells. The gene discussed is FOS; the disease is neoplasm.